EFFECT ON BONE METABOLISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS OF ORAL HYPOGLYCAEMIC AGENTS
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2018, Vol 5, Issue 9
Abstract
BACKGROUND This study evaluated the effect of treatment of many oral hypoglycaemic agents on bone metabolism in patients with type 2 diabetes mellitus and occurrence of osteoporosis. MATERIALS AND METHODS This cross-sectional study was conducted in Department of General Medicine of Chalmeda Ananda Rao Institute of Medical Sciences, Karimnagar, Telangana, between January 2015 to February 2017. RESULTS 250 patients were screened for this study. From these, 50 patients with T2DM were included in the study who were satisfying the inclusion criteria. Age in years of patients with T2DM was 50.5±4.8 and in control group, age in years was 50.8±2.5. BMI in kg/m2 in patients with T2DM was 25.6±6.9, in control group, BMI was 28.5±3.88 kg/ m2 . Median duration of menopause was 5 in patients with T2DM and it was 5 in control group. There were more women in both the groups i.e. in patients with T2DM, 36/50; in control group, 35/50. The mean duration of T2DM in the study group was 6.09±1.9 years; mean HbA1C was 8.0±1%. 15 patients were using either TZD alone or in combination with other OHA, the remaining 35 were using other OHA alone or in combination. Overall BMD was in postmenopausal was less significantly at the neck of femur compared to lumbar spine in anterior–posterior view. The BMD in g/cm2 and z-scores at NOF and LSAP were comparable between the study group and control group. There was no significant difference in the presence of BMD, osteopenia and osteoporosis between both the groups. One-way ANOVA did not show any significant difference between BMD NOF and LSAP, T-scores at level of NOF and LSAP, Z-scores at level of NOF and LSAP on comparing between patients with T2DM treated with TZD, patients with T2DM treated with other OHA and control group. CONCLUSION For a period of two years or more, the present study shows that the use of OHA does not significantly affect the BMD in patients with T2DM.
Authors and Affiliations
Narender Katakam, Sridevi Durgaraju
Keywords
Related Articles
- EP ID EP474145
- DOI 10.18410/jebmh/2018/156
- Views 84
- Downloads 0
SEMINOGRAM IN MALE PARTNERS OF INFERTILE COUPLES ATTENDING INFERTILITY CLINIC IN CALICUT, KERALA
BACKGROUND Rising trends of male factor infertility has been reported worldwide. Lifestyle, food habits and even cell phone usage has been implicated in this. The aim of this study is to assess the prevalence of seminal...
A COMPARATIVE STUDY OF THE IMAGING AND TREATMENT MODALITIES IN THE MANAGEMENT OF CHOLEDOCHOLITHIASIS
AIM The objectives of this study are to compare the investigative modalities used in the diagnosis and to compare the treatment undertaken in the management of patients with choledocholithiasis. MATERIAL AND METHODS Data...
HEPATOBILIARY ASCARIASIS: 2 CASE REPORT
Hepatobiliary ascariasis is a relatively uncommon helminthic disease occasionally found in Indian subcontinent and third world country. They commonly present as right hypochondrial pain with mild jaundice. Vomiting may a...
A STUDY OF PULMONARY FUNCTION TESTS IN TRAFFIC POLICEMEN IN KOTTAYAM DISTRICT AND NORMAL HEALTHY ADULTS
BACKGROUND Environmental pollution and human efforts for the betterments of living standards are the two sides of the same coin. In the wake of industrialisation and ever increasing population, the basic amenities of lif...
PERCUTANEOUS BIPLANAR EXTERNAL FIXATOR METHOD FOR TREATMENT OF CALCONEAL FRACTURES
Calcaneal fracture, the most common tarsal bone fracture, occurs predominantly in manual labors and subsequently has got considerable socioeconomic implications. Treatment modality which can offer early weight bearing an...